source
- Opinion: STAT+: I’m a cardiologist. I’m a little puzzled about the blockbuster new study on deprescribing statinsSTAT columnist Vishal Khetpal examines the STREAM trial and its findings about discontinuing use of statins.STAT · 46m ago↗ source
- STAT+: Before midterm losses, MAHA spent on itself instead of candidatesMAHA PAC spent more at a D.C. steakhouse than it did on the House race of a key ally.STAT · 46m ago↗ source
- FDA approves Infilbray, first therapy for neurological symptoms of Type 3 Gaucher diseaseThe U.S. Food and Drug Administration has approved Infilbray (venglustat) tablets for treating the neurological manifestations of Type 3 Gaucher disease in adults and children weighing at least 15…fda press · 15h ago